Time in Tight Range for Patients With Type 1 Diabetes: The Time Is Now, or Is It Too Soon?

被引：3
|
作者：
Hamidi, Vala [1 ]
Pettus, Jeremy H. [1 ]
机构：
[1] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA
来源：
DIABETES CARE | 2024年 / 47卷 / 05期
关键词：
ASSOCIATION;
D O I：
10.2337/dci23-0092
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：782 / 784
页数：3
相关论文
共 50 条
  • [21] CGM Time Below Range Predicts Epinephrine Response to Hypoglycemia in Patients with Type 1 Diabetes
    Thomas, Robert L.
    Gregory, Justin M.
    Giovannetti, Erin R.
    Boeder, Schafer C.
    Pettus, Jeremy
    [J]. DIABETES, 2023, 72
  • [22] The influence of time in range on daily mood in adults with type 1 diabetes
    Polonsky, W. H.
    Fortmann, A. L.
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2020, 34 (12)
  • [23] Greater Sleep Variability Is Associated with Less Time in Range of Glucose Levels in Patients with Type 1 Diabetes
    Martyn-Nemeth, Pamela
    Abu Irsheed, Ghada
    Park, Minsun
    Steffen, Alana D.
    Burke, Larisa
    Pratuangtham, Sarida
    Baron, Kelly
    Duffecy, Jennifer
    Perez, Rosanne
    Quinn, Laurie T.
    Withington, Meg Clark
    Saleh, Adam H.
    Loiacono, Bernardo
    Mihailescu, Dan
    Reutrakul, Sirimon
    [J]. DIABETES, 2023, 72
  • [24] Training Load and Time-in-Range Affect Sleep Time of Professional Cyclists with Type 1 Diabetes
    Scott, Sam N.
    Fontana, Federico Y.
    Martinez-Gonzalez, Borja
    Hayes, Charlotte A.
    Lagrou, Peter H., Sr.
    Marcora, Samuele
    Zueger, Thomas
    Stettler, Christoph
    [J]. DIABETES, 2020, 69
  • [25] Aiming for the Best Glycemic Control Beyond Time in Range: Time in Tight Range as a New Continuous Glucose Monitoring Metric in Children and Adolescents with Type 1 Diabetes Using Different Treatment Modalities
    Passanisi, Stefano
    Piona, Claudia
    Salzano, Giuseppina
    Marigliano, Marco
    Bombaci, Bruno
    Morandi, Anita
    Alibrandi, Angela
    Maffeis, Claudio
    Lombardo, Fortunato
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2024, 26 (03) : 161 - 166
  • [26] TIME-IN-RANGE: A TOP METRIC FOR ENDOCRINOLOGISTS TREATING PATIENTS WITH TYPE 1 DIABETES AND TYPE 2 ON INTENSIVE INSULIN
    Tait, J.
    Velcani, F.
    Shoger, E.
    Wood, R.
    Kaufman, F.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A108 - A108
  • [27] Preventing diabetes - The time is now
    Teutsch, S
    [J]. DIABETES CARE, 2006, 29 (06) : 1447 - 1448
  • [28] 12-Month Time in Tight Range Improvement with Advanced Hybrid-Closed Loop System in Adults with Type 1 Diabetes
    Nigi, Laura
    Batzibal, Maria De Los Angeles Simon
    Cataldo, Dorica
    Dotta, Francesco
    [J]. DIABETES THERAPY, 2024,
  • [29] Rosiglitazone monotherapy for type 2 diabetes mellitus—too soon to ADOPT?
    Peter Gæde
    Oluf Pedersen
    [J]. Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 456 - 457
  • [30] Exploring time in tight range targets (TITR) in drug-naive Japanese individuals with type 2 diabetes
    Ishiguro, Mizuki
    Ando, Kiyotaka
    Nishimura, Rimei
    [J]. ACTA DIABETOLOGICA, 2024, 61 (07) : 933 - 936
12345